"Over the past decade, digital health technologies (DHTs) have grown rapidly, driven by innovations such as electronic health records and accelerated by the COVID-19 pandemic. Increased funding and regulatory support have further pushed the sector’s expansion. Despite early success, many DHT companies struggle to scale, with notable examples like Pear Therapeutics and Proteus Digital Health, which both declared bankruptcy after initial breakthroughs. These cases highlight the challenges of sustaining growth in a highly regulated health care environment. While there is research on success factors across industries, a gap remains in understanding the specific challenges faced by growth-stage DHT companies..." Lire la suite
Success Factors of Growth-Stage Digital Health Companies: Systematic Literature Review
JMIR, 11/12/2024
Partagé par :
Seddik Touaoula

Informations liées
Thématiques
Accueil Télémédecine
Evaluation
Sécurité
Définitions
Patients - Quantified Self - Empowerment
Accueil Urgences
Essais cliniques